Exane Derivatives’s ProShares Trust UltraShort Lehman 20+ Year Treasury TBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100
Closed -$3.45K 967
2020
Q4
$3.45K Hold
100
﹤0.01% 582
2020
Q3
$6.1K Buy
+100
New +$1.54K ﹤0.01% 492

Other funds holding TBT

Exane Derivatives's TBT Position: Q1 2022 in Review

Exane Derivatives sold out of ProShares Trust UltraShort Lehman 20+ Year Treasury (TBT) in Q1 2022, closing a stake of 16,500 shares — an estimated $279K sold.

Exane Derivatives first reported a position in TBT in Q4 2014 and held it in 11 quarters. The position peaked at $1.34M in Q1 2016. 108 funds tracked by Wall St. Rank hold TBT as of Q1 2022.

  • Exane Derivatives reported no remaining ProShares Trust UltraShort Lehman 20+ Year Treasury position as of Q1 2022 after selling out during the quarter.
  • Exane Derivatives sold 16,500 ProShares Trust UltraShort Lehman 20+ Year Treasury shares in Q1 2022, an estimated $279K.
  • Exane Derivatives first reported a position in ProShares Trust UltraShort Lehman 20+ Year Treasury in Q4 2014 and held it in 11 quarters.
  • Exane Derivatives's ProShares Trust UltraShort Lehman 20+ Year Treasury position peaked at $1.34M in Q1 2016.
  • 108 funds tracked by Wall St. Rank held ProShares Trust UltraShort Lehman 20+ Year Treasury as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.